Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom
Dutasteride 0.5 mg soft capsules.
| Pharmaceutical Form |
|---|
|
Capsule, soft. The capsules are opaque, yellow, oblong soft gelatin capsules filled with an oily and yellowish liquid, without printing. Soft capsules dimensions are: 19 ± 0.8 mm x 6.9 ± 0.4 mm |
Each soft capsule contains 0.5 mg dutasteride.
Excipient with known effect: Each soft capsule contains lecithin (which may contain soya oil).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dutasteride |
Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT. |
| List of Excipients |
|---|
|
Capsule contents: Butylhydroxytoluene (E321) Capsule shell: Gelatin Other ingredients: Triglycerides, medium chain |
White opaque PVC/PVDC – Aluminium blisters containing 10, 30, 50, 60, 90 capsules and perforated blister packs of 10x1, 30x1, 50x1, 60x1 and 90x1 capsule.
Not all pack sizes may be marketed.
Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom
PL 20075/0423
23/09/2015
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
